Colorectal cancer prevalence in India • India has the 3rd highest cases of colorectal cancer in the world and 10% of the total cancer cases in India are based on registered cases only. • Colorectal Cancer is the 4th highest cancer in Men at a CAGR 10.6%. • Estimated number of new cases 2020-2040 in India will be up by 57.5%. • India’s mortality rate is the highest in the world due to late-stage detection of the disease. Current Challenges in India • There’s a significant lack of awareness about colorectal cancer in India, leading to late-stage diagnoses and poorer outcomes. • Public health campaigns and educational initiatives are limited compared to other types of cancers. • Rising incidence rates - among top ten cancers in India due to various factors, including lifestyle changes, dietary habits, and increasing life expectancy. • Limited access to screening facilities • High costs associated with screening facilities. • Cultural and social stigmas. Current and future colorectal cancer screening strategies • Throughout the world, the most used approach for colorectal cancer screening is the faecal immunochemical test (FIT). • Colonoscopy is the most common screening modality in the USA and is also used in many other regions, including, for example, parts of Germany and Poland. • offering non-invasive tests as a screening option effectively improves adherence to screening. • There are five blood tests currently being studied as a potential alternative to FIT and colonoscopy for CRC screening. • Novel imaging tests, such as the colon capsule, mR colonography and the Ct capsule, are also undergoing active investigation. • Recovery from deferred screening due to the CovID-19 pandemic will require the use of non-invasive screening options to help select patients for colonoscopy. Innovative Early detection from Biosysion Colocam DX - FIT Tube – self Test ColoCam DX FIT Tube® -is most advanced non-invasive Fecal Immunochemical Test is reliable, accurate, and affordable. FIT colon cancer screening test is a proven and recommended colon cancer screening test used by doctors and hospitals worldwide – over-the-counter self-test kit. The ColoCam Tube® self-test is easy to perform in the comfort of your own home and results are ready within five minutes. With ColoCam Tube®, no prescription, doctor's visit, or mailing a sample back to a laboratory is required. ColoCam DX - FIT DNA  Colorectal cancer begins when cells in the intestine undergo genetic mutations. Tumour cells shed into the intestines. Stool samples can be examined for tumour DNA using PCR technology.  Polymerase chain reaction (PCR) is used to rapidly make millions to billions of copies of a specific DNA sample and only requires a very small sample of DNA to amplify it large enough for detailed study.  ColoCam DX® - FIT DNA utilizes proprietary methods to analyse the cell DNA for specific Tumour markers.  ColoCam DX® - FIT DNA is designed to detect tumour DNA and detect 95% of colorectal cancer cases – often in the earliest stages of the disease. *  Ease-of-use drives ongoing patient adherence as the ColoCam DX® - FIT DNA method requires very small samples compared to screening method.